← Royal Fitness Club Educational information only — not a substitute for medical advice. Read disclaimer ·
JB Chemicals and Pharmaceuticals Ltd, an Indian manufacturer, is recalling Cetirizine Hydrochloride Tablets USP 5 mg in the United States. Reason given: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg.
Hero illustration prompt: Premium editorial health news illustration, ultra-HD.
Product: Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B..
Reason: Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
This is a US recall of batches made for the US market. It does not by itself mean the same brand sold in India is affected.
Do not stop a prescribed medicine on your own. If you are worried about a medicine you take, ask your pharmacist or doctor, and check CDSCO's monthly drug alerts.
Taken from the openFDA drug enforcement record linked below. openFDA data is published by the FDA and may be revised.
US Food and Drug Administration — openFDA enforcement reportsOfficial source
This item is general educational guidance. It does not diagnose, prescribe or change doses. It summarises the official source linked above, which is the authority — check it for the latest figures.
This website provides general educational information and is not a substitute for professional medical diagnosis, treatment or emergency care. Always consult a qualified healthcare professional.